Table 4.
Clinical outcomes from keratitis patients.
| Sheen Negative (n=49) |
Sheen Positive (n=19) |
p-value | |
|---|---|---|---|
| Age | 56.4 ± 21.1 years | 49.3 ± 23.6 years | p=0.2322 |
| Female | 73.5% (36/49) | 42.1% (8/19) | p=0.0152 |
| Symptom duration | 3.5 ± 2.5 days (N=47) |
3.3 ± 4.6 days (N=19) |
p=0.8446 |
| Average Epi Defect Size | 26.7 ± 31.1 mm2 (N=44) | 12.5 ± 21.2 mm2 (N=16) | p=0.0979 |
| Average Infiltrate Size | 25.0 ± 31.3 mm2 (N=44) | 14.0 ± 21.0 mm2 (N=17) | p=0.1861 |
| Hypopyon present | 51.1% (24/47) | 57.9% (11/19) | p=0.1180 |
| Average Initial VA | 1.70 ± 0.9 LogMAR | 1.73 ± 0.9 LogMAR | p=0.9165 |
| Average Final VA | 1.1 ± 1.0 LogMAR | 0.42 ± 0.56 LogMAR | p=0.0106 |
| Average time to resolution | 36.3 ± 38.2 days | 34.8 ± 28.5 days | p=0.8835 |
| Management with Fluoroquinolone drops | 85.7% (42/49) | 89.5% (17/19) | p=0.8824 |
| Management with Fortified drops | 83.7% (41/49) | 73.7% (14/19) | p=0.6806 |
| Management with oral fluoroquinolone | 46.9% (23/49) | 36.8% (7/19) | p=0.5744 |
| Management with topical steroids | 53.1% (26/49) | 42.1% (8/19) | p=0.5664 |
| PKP | 14.3% (7/49) | 0% (0/19) | p=0.1778 |
| Enucleation | 8.2% (4/49) | 0% (0/19) | p=0.5702 |
VA, visual acuity regarding logMAR values (lower indicates better visual acuity).
PKP, penetrating keratoplasty (corneal transplant). Bold text indicates significant differences.